6505--Ropinirole Tablet

SOL #: 36E79726R0019Pre-Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NAC PHARMACEUTICALS (36E797)
HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 9, 2026
2
Response Deadline
May 7, 2026, 7:30 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The VA National Acquisition Center intends to issue an unrestricted Request for Proposal (RFP) 36E79726R0019 for Ropinirole HCL Tablets. This procurement will supply the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA plans to award a single contract to a responsible offeror capable of providing an uninterrupted source of supply. The solicitation is expected on or about April 23, 2026, with proposals due by May 07, 2026.

Scope of Work

This opportunity is for the supply of Ropinirole HCL Tablets in various dosages and package sizes. Offerors must provide the exact drug name as it appears on the label and a unique NDC/UPC number for each item. The standard package unit is bottles. Estimated annual usage for different strengths (0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg, 5mg) and package sizes (100 and 500 tablets per bottle) is detailed in the presolicitation notice.

Contract & Timeline

  • Type: Unrestricted procurement, commercial item format (FAR Part 12).
  • Duration: One base year plus four pre-priced one-year option periods.
  • Distribution: Through the VA's Pharmaceutical Prime Vendor Programs.
  • Set-Aside: Unrestricted.
  • NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing).
  • Solicitation Number: 36E79726R0019.
  • Solicitation Issue Date: On or about April 23, 2026.
  • Proposal Due: May 07, 2026, 2:30 PM Central Time, Chicago, USA.
  • Published: April 09, 2026.

Submission & Evaluation

Proposals will be accepted from all responsible sources and must be timely received to be considered. The solicitation will be issued electronically on www.beta.sam.gov, where all future amendments and documents will also be available. No paper copies or telephone requests will be accepted. Offerors are advised to continuously monitor the website for updates.

Point of Contact

Michael Olszewski, michael.olszewski@va.gov, 708-786-4966.

People

Points of Contact

michael.olszewski@va.govMichael OlszewskiPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Pre-Solicitation
Posted: Apr 9, 2026
6505--Ropinirole Tablet | GovScope